Recently, the innovative product Recombinant Humanized Type III Collagen Solution for injection of Shanxi Jinbo Bio-pharmaceutical Co., Ltd. is approved by China NMPA.

This product is a colorless or almost white liquid composed of recombinant humanized type III collagen and 0.9% physiological saline. It is applied for filling facial dermal tissue to correct dynamic wrinkles in the forehead (including eyebrow lines, forehead lines, and fishtail lines). The recombinant collagen biomaterial used in this product can be assembled into collagen fiber networks, which support cells and tissues in dermal collapse, and physically fills those areas. The immunogenicity risk of the product is controllable, as the substances will gradually be decomposed and absorbed by the collagenase after injection.

The NMPA will strengthen the post-marketing surveillance of the product to protect the safety of medical devices used by patients.